VJOncology is committed to improving our service to you

ESMO 2019 | Nab-paclitaxel and gemcitabine in soft tissue sarcoma: trial update

VJOncology is committed to improving our service to you

Yannis Metaxas

Speaking from the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain, Yannis Metaxas, MD, Cantonal Hospital Grison, Chur, Switzerland, discusses the results from the phase I part of the phase I/II SAKK 57/16 trial (NCT03524898). This study investigated nab-paclitaxel and gemcitabine in soft tissue sarcoma.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter